Vendor, Baltimore, MD
Nka Bio, Inc.
UEI F6TLH1UTJG53, CAGE 9LEW0
2 awards and $1,318,509 obligated between September 17, 2024 and February 19, 2026, 100% under full and open competition, against 557.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $1,318,509 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 2 |
| Small Business Set Aside - Total | 2 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| FA864925P0362Purchase Order, July 15, 2025, Full and Open Competition After Exclusion of Sources, 115 offers | FA8649 USAF SBIR STTR Cntrctng AFRLDepartment of the Air Force | Anti-Shock Injection to Improve Combat Casualty CareNAICS 541715, PSC AC32 | $1,245,837 |
| FA864924P0719Purchase Order, September 17, 2024, Full and Open Competition After Exclusion of Sources, 999 offers | FA8649 USAF SBIR STTR Cntrctng AFRLDepartment of the Air Force | Anti-Shock Toxin Antibody Drug for Combat Casualty CareNAICS 541715, PSC AC32 | $72,672 |
- Places of performance
- Maryland
- Product and service codes
- AC32 National Defense R&D Services; Defense-Related Activities; Applied Research
- Transactions
- 5 across 2 awards